Tianjin KingYork Group Co. Ltd.
http://www.kingyork.biz
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Tianjin KingYork Group Co. Ltd.
Deals In Depth: May 2013
AbbVie paid $70 million up front in an option-based deal with Alvine, and both Valeant and Actavis completed $8 billion-plus acquisitions, of B&L and Warner Chilcott, respectively. IPOs accounted for $1 billion of the $2.7 billion in biopharma financing; device firms raised $342 million.
Deals Shaping The Medical Industry, July 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice